Alerts will be sent to your verified email
Verify Email
JAGSNPHARM
|
Jagsonpal Pharma
|
Gufic Biosciences
|
Bharat Parenterals
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.8 % | 26.14 % | 16.48 % |
|
5yr average Equity Multiplier
|
1.31 | 2.82 | 1.56 |
|
5yr Average Asset Turnover Ratio
|
1.18 | 1.1 | 1.12 |
|
5yr Avg Net Profit Margin
|
7.67 % | 9.03 % | 9.36 % |
|
Price to Book
|
5.4 | 8.41 | 5.11 |
|
P/E
|
37.26 | 39.03 | 34.46 |
|
5yr Avg Cash Conversion Cycle
|
-6.79 Days | -18.02 Days | 72.73 Days |
|
Inventory Days
|
60.26 Days | 77.22 Days | 36.63 Days |
|
Days Receivable
|
25.87 Days | 81.36 Days | 106.98 Days |
|
Days Payable
|
67.96 Days | 175.58 Days | 87.71 Days |
|
5yr Average Interest Coverage Ratio
|
51.15 | 10.3 | 30.62 |
|
5yr Avg ROCE
|
15.71 % | 33.27 % | 23.26 % |
|
5yr Avg Operating Profit Margin
|
11.17 % | 17.37 % | 16.78 % |
|
5 yr average Debt to Equity
|
0.03 | 0.73 | 0.08 |
|
5yr CAGR Net Profit
|
29.92 % | 29.43 % | 18.21 % |
|
5yr Average Return on Assets
|
9.04 % | 10.17 % | 10.57 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
68.09 % | 72.51 % | 73.27 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.25 % | 6.76 % | -1.15 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -6.16 % | 0.0 |
|
Jagsonpal Pharma
|
Gufic Biosciences
|
Bharat Parenterals
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
